iLASIK vision correction combines AMO technologies

Article

Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision.

Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision (iLASIK vision correction).

The iLASIK procedure is a consumer-facing brand platform that communicates the advantage of two of the company's technologies: femtosecond flap creation technology (IntraLase FS) and custom laser vision correction (Advanced CustomVue). The company presented the re-branded LASIK procedure during a user group meeting at the Hilton Riverside Hotel here prior to the American Academy of Ophthalmology annual meeting.

According to Ron Bache, global vice president of marketing, AMO refractive surgery, the procedure:

•Provides one integrated platform that features advanced technology at every step.

•Can be actively marketed to all segments of "Generation i" (college students, baby boomers, and even fighter pilots).

•Establishes the company as a committed partner that is making an unmatched investment in LASIK.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.